CPIX vs. ASMB, REPH, LLY, JNJ, MRK, ABBV, PFE, BMY, ZTS, and RPRX
Should you be buying Cumberland Pharmaceuticals stock or one of its competitors? The main competitors of Cumberland Pharmaceuticals include Assembly Biosciences (ASMB), Recro Pharma (REPH), Eli Lilly and Company (LLY), Johnson & Johnson (JNJ), Merck & Co., Inc. (MRK), AbbVie (ABBV), Pfizer (PFE), Bristol-Myers Squibb (BMY), Zoetis (ZTS), and Royalty Pharma (RPRX).
Cumberland Pharmaceuticals (NASDAQ:CPIX) and Assembly Biosciences (NASDAQ:ASMB) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, risk, valuation, analyst recommendations, profitability, media sentiment, community ranking and earnings.
Cumberland Pharmaceuticals has higher revenue and earnings than Assembly Biosciences.
Assembly Biosciences has a net margin of 0.00% compared to Cumberland Pharmaceuticals' net margin of -21.67%. Cumberland Pharmaceuticals' return on equity of 0.21% beat Assembly Biosciences' return on equity.
Cumberland Pharmaceuticals has a beta of 0.23, suggesting that its stock price is 77% less volatile than the S&P 500. Comparatively, Assembly Biosciences has a beta of 0.63, suggesting that its stock price is 37% less volatile than the S&P 500.
In the previous week, Assembly Biosciences had 3 more articles in the media than Cumberland Pharmaceuticals. MarketBeat recorded 3 mentions for Assembly Biosciences and 0 mentions for Cumberland Pharmaceuticals. Assembly Biosciences' average media sentiment score of 0.63 beat Cumberland Pharmaceuticals' score of 0.00 indicating that Assembly Biosciences is being referred to more favorably in the news media.
Assembly Biosciences received 55 more outperform votes than Cumberland Pharmaceuticals when rated by MarketBeat users. Likewise, 59.31% of users gave Assembly Biosciences an outperform vote while only 44.74% of users gave Cumberland Pharmaceuticals an outperform vote.
15.5% of Cumberland Pharmaceuticals shares are held by institutional investors. Comparatively, 19.9% of Assembly Biosciences shares are held by institutional investors. 43.3% of Cumberland Pharmaceuticals shares are held by insiders. Comparatively, 5.1% of Assembly Biosciences shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
Summary
Assembly Biosciences beats Cumberland Pharmaceuticals on 8 of the 13 factors compared between the two stocks.
Get Cumberland Pharmaceuticals News Delivered to You Automatically
Sign up to receive the latest news and ratings for CPIX and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding CPIX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Cumberland Pharmaceuticals Competitors List
Related Companies and Tools
